Successful uses of magnesium sulfate for torsades de pointes in children with long QT syndrome

Pediatrics International

Volumn 48, Issue 2, 2006, Pages 112-117

  Hoshino, Kenji ^a,c   Ogawa, Kiyoshi ^a   Hishitani, Takashi ^a   Isobe, Takeshi ^b   Etoh, Yoshikatsu ^c  

^a SAITAMA CHILDREN'S MEDICAL CENTER   (Japan)

^b Ibaraki Children's Hospital   (Japan)

^c JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Children; Long QT syndrome; Magnesium; Magnesium concentration; Torsades de pointes

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DISOPYRAMIDE; MAGNESIUM SULFATE; MEXILETINE;

ARTICLE; ATRIOVENTRICULAR BLOCK; BOLUS INJECTION; CHILD; CHILDHOOD DISEASE; CLINICAL ARTICLE; CONTINUOUS INFUSION; CONTROLLED STUDY; DRUG EFFICACY; DRUG MECHANISM; ELECTROCARDIOGRAPHY; HEART VENTRICLE EXTRASYSTOLE; HEART VENTRICLE SEPTUM DEFECT; HUMAN; INFANT; INFUSION RATE; LONG QT SYNDROME; MAGNESIUM BLOOD LEVEL; MALE; NEWBORN; PRIORITY JOURNAL; QT INTERVAL; SYNCOPE; TORSADE DES POINTES;

ANTI-ARRHYTHMIA AGENTS; CHILD; CHILD, PRESCHOOL; COMORBIDITY; ELECTROCARDIOGRAPHY; HUMANS; INFANT; INFANT, NEWBORN; INFUSIONS, INTRAVENOUS; LONG QT SYNDROME; MAGNESIUM SULFATE; MALE; TORSADES DE POINTES; TREATMENT OUTCOME;

EID: 33645405596     PISSN: 13288067     EISSN: 1442200X     Source Type: Journal    
DOI: 10.1111/j.1442-200X.2006.02177.x     Document Type: Article

References (32)

1. Agus ZS Morad M. Modulation of cardiac ion channels by magnesium. Annu. Rev. Physiol. 1991 53 299 307.
2. Tsuij H Venditti FJ Evans JC Larson MG Levy M. The association of levels of serum potassium and magnesium with ventricular premature complexes (the Framingham Heart Study). Am. J. Cardiol. 1994 74 232 5.
3. Arsenian MA. Magnesium and cardiovascular disease. Prog. Cardiovasc. Dis. 1993 4 271 310.
4. Gottlieb SS Fisher ML Pressel MD Patten RD Weinberg M Greenberg N. Effects of intravenous magnesium sulfate on arrhythmias in patients with congestive heart failure. Am. Heart J. 1993 125 1645 50.
5. Leier CV Dei Cas L Metra M. Clinical relevance and management of the major electrolyte abnormalities in congestive heart failure: hyponatremia, hypokalemia, and hypomagnesemia. Am. Heart J. 1994 128 564 74.
6. Yusuf S Teo K Woods K. Intravenous magnesium in acute myocardial infarction. Circulation 1993 87 2043 6.
7. Woods KL Fletcher S Roffe C Haider Y. Intravenous magnesium sulfate in suspected acute myocardial infarction: results of the second Leicester Intravenous Magnesium Intervention Trial (LIMIT-2). Lancet 1992 339 1553 8.
8. Tzivoni D Keren A Cohen AM et al. Magnesium therapy for torsades de pointes. Am. J. Cardiol. 1984 53 528 30.
9. Tzivoni D Banai S Schuger C et al. Treatment of torsade de pointes with magnesium sulfate. Circulation 1988 77 392 7.
10. Hoshino K Yano I Fujiwara M Ogawa K. A child case of torsade de pointes in patient with long QT syndrome: only magnesium sulfate was effective. Acta Cardiol. Paediatr. Jpn. 1992 8 317 22.
11. Hoshino K Ogawa K Kitazawa R Nakamura Y Uehara R. Effect of varying condition on ionized magnesium measurement. Magnesium 1997 16 7 15.
12. Hoshino K Ogawa K Hishitani T Kitazawa R. Characteristics of improved NOVA magnesium ion-selective electrode: changes of ionized magnesium values and reference interval in healthy children. Magnes. Res. 2001 14 203 10.
13. Bazett HC. An analysis of the time-relation of electrocardiograms. Heart 1920 7 353 70.
14. Bonatti V Rolli A Botti G. Recording of monophasic action potentials of the right ventricle in long QT syndromes complicated by severe ventricular arrhythmias. Eur. Heart J. 1983 4 168 72.
15. Gavrilescu S Luca C. Right ventricular monophasic action potentials in patients with long QT syndrome. Br. Heart J. 1978 40 1014 18.
16. Jackman WM Clark M Friday KJ Aliot EM Anderson J Lazzara R. Ventricular tachyarrhythmias in the long QT syndrome. Med. Clin. North Am. 1984 68 1079 109.
17. Levine JH Spear JF Guarnieri T et al. Cesium chloride-induced long QT syndrome: demonstration of after-depolarization and triggered activity in vivo. Circulation 1985 72 1092 104.
18. Schechter E Freeman CC Lazzara R. After-depolarizations as a mechanism for the long QT syndrome: electrophysiologic studies of a case. J. Am. Coll. Cardiol. 1984 3 1556 61.
19. Tan HL Hou CJ Y Lauer MR Sung RJ. Electrophysiologic mechanisms of the long QT interval syndromes and torsades de pointes. Ann. Intern. Med. 1995 122 710 14.
20. Kurita T Ohe T Shimizu W Hotta D Shimomura K. Early after-depolarization in a patient with complete atrioventricular block and torsades de pointes. PACE Pacing Clin. Electrophysiol. 1993 16 33 8.
21. Wang Q Curran ME Splawski I et al. Positional cloning of a novel potassium gene: KVLQT1 mutations cause cardiac arrhythmias. Nat. Genet. 1996 12 17 23.
22. Brown AM Birnbaumer L. Ionic channels and their regulation by G protein subunits. Annu. Rev. Physiol. 1990 52 197 213.
23. + channels. Cell 1990 61 769 76.
24. Kaseda S Gilmour RF Zipes DP. Depressant effect of magnesium on early afterdepolarizations and triggered activity induced by cesium, quinidine and 4-aminopyridine in canine cardiac Purkinje fibers. Am. Heart J. 1989 118 458 66.
25. Attwell D Cohen I Eisner D Ohba M Ojeda C. The steady state TTX-sensitive ('window') sodium current in cardiac Purkinje fibers. Pflugers Arch. 1979 379 137 42.
26. Iseri LT Fairshter RD Hardemann JL Brodsky MA. Magnesium and potassium therapy in multifocal atrial tachycardia. Am. Heart J. 1985 110 789 94.
27. Allen BJ Brodsky MA Capparelli EV Luckett CR Iseri LT. Magnesium sulfate therapy for sustained monomorphic ventricular tachycardia. Am. J. Cardiol. 1989 64 1202 4.
28. Kulkarni P Bhattacharya S Petros AJ. Torsade de pointes and long QT syndrome following major blood transfusion. Anaesthsia 1992 47 125 7.
29. DiCarlo LA Jr. Morady F Buitleir M Krol RB Schurig L Annesley TM. Effects of magnesium sulfate on cardiac conduction and refractoriness in humans. J. Am. Coll. Cardiol. 1986 7 1356 62.
30. Kulick DL Hong R Ryzen E et al. Elelctrophysiologic effects of intravenous magnesium in patients with normal conduction systems and no clinical evidence of significant cardiac disease. Am. Heart J. 1988 115 367 73.
31. Rogiers P Vermeier W Kesteloot H Stroobandt R. Effect of the infusion of magnesium sulfate during atrial pacing on ECG intervals, serum electrolytes, and blood pressure. Am. Heart J. 1989 117 1278 83.
32. Kost GJ. New whole blood analyzers and their impact on cardiac and critical care. Crit. Rev. Clin. Lab. Sci. 1993 30 153 202.